Poststroke Depression of Clinical Trial Registration

NCT ID: NCT03863951

Last Updated: 2019-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-20

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aim to explore the relationship between gut microbiota composition and earlier poststroke depression via 16S rRNA sequencing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, patients with first ever acute ischemic stroke were studied. According to the psychological assessment, patients were divided into two groups according to whether or not there was a PSD at the earlier stage of stroke. Clinical biological data and blood and feces samples were collected. Firstly, 16srDNA sequencing was used to study the difference in the composition and diversity of intestinal microbial communities in the two groups of patients. Then the two groups selected individual representative samples and conducted macro genome sequencing. At the same time, by analyzing the correlation between the intestinal flora and the clinical risk factors and neurotransmitters in early PSD patients, the key functional bacteria related to PSD were identified.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with poststroke depression

No intervention

No interventions assigned to this group

Patients without poststroke depression

No intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed with the first ever acute ischemic stroke occurring within 2 weeks and were confirmed by CT or MRI,
* has no history of depression or use of antidepressants or antipsychotics,
* were competent to consent to take part in this research.

Exclusion Criteria

* significant acute or severe illness such as infection,heart failure and tumor,
* previous diagnosis of depression or other mental disorder or who had recently accepted antidepressants or antipsychotics,
* antibiotics in the last two weeks,
* severe aphasia or dysarthria,irritable bowel syndrome,asthma,and pregnant or lactating women,
* a previous history of neurological illness including AD and PD,
* Inflammatory bowel disease,
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital Xi'an Jiaotong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yurong Zhang, PhD

Role: STUDY_CHAIR

First Affiliated Hospital Xi'an Jiaotong University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yurong Zhang

Xi'an, Shaanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yurong Zhang, PhD

Role: CONTACT

0086-029-85323443

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yurong Zhang

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XJTU1AF-CRF-2018-024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment for Post-Stroke Depression
NCT00029172 COMPLETED PHASE4
Gut Microbiome and Depression
NCT05808101 TERMINATED